Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 21% ± 7% | |
glutamatergic neuron | 3 studies | 27% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 676.19 | 1445 / 1445 | 100% | 9.37 | 183 / 183 |
intestine | 100% | 794.26 | 966 / 966 | 99% | 10.16 | 524 / 527 |
stomach | 100% | 770.74 | 359 / 359 | 99% | 9.81 | 284 / 286 |
brain | 99% | 456.98 | 2622 / 2642 | 100% | 6.79 | 703 / 705 |
pancreas | 100% | 781.65 | 328 / 328 | 99% | 7.48 | 176 / 178 |
bladder | 100% | 665.62 | 21 / 21 | 99% | 8.46 | 498 / 504 |
uterus | 100% | 525.33 | 170 / 170 | 99% | 7.69 | 453 / 459 |
lung | 99% | 546.27 | 570 / 578 | 100% | 7.03 | 1152 / 1155 |
prostate | 100% | 813.15 | 245 / 245 | 98% | 5.23 | 492 / 502 |
breast | 100% | 556.16 | 459 / 459 | 98% | 6.00 | 1095 / 1118 |
thymus | 100% | 759.57 | 653 / 653 | 98% | 5.63 | 590 / 605 |
kidney | 100% | 614.85 | 89 / 89 | 96% | 6.69 | 867 / 901 |
ovary | 100% | 590.89 | 180 / 180 | 96% | 5.65 | 412 / 430 |
adrenal gland | 100% | 967.01 | 258 / 258 | 93% | 4.66 | 214 / 230 |
liver | 100% | 548.47 | 226 / 226 | 91% | 4.85 | 369 / 406 |
skin | 100% | 606.07 | 1807 / 1809 | 89% | 6.99 | 421 / 472 |
muscle | 100% | 671.53 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1222.26 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.06 | 1 / 1 |
adipose | 100% | 500.40 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 352.94 | 1321 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 5.29 | 44 / 45 |
lymph node | 0% | 0 | 0 / 0 | 97% | 9.55 | 28 / 29 |
heart | 96% | 441.49 | 828 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 475.31 | 751 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 64% | 3.70 | 51 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0070126 | Biological process | mitochondrial translational termination |
GO_0005739 | Cellular component | mitochondrion |
GO_0003747 | Molecular function | translation release factor activity |
GO_0016149 | Molecular function | translation release factor activity, codon specific |
Gene name | MTRF1 |
Protein name | MTRF1 protein (Mitochondrial translation release factor 1) (Mitochondrial translational release factor 1, isoform CRA_b) Mitochondrial translation release factor 1 Peptide chain release factor 1, mitochondrial (MRF-1) (MtRF-1) |
Synonyms | hCG_32761 |
Description | FUNCTION: Mitochondrial peptide chain release factor that directs the termination of translation in response to the peptide chain non-canonical stop codons AGG and AGA . Non-canonical termination codons AGG and AGA are found at the end of MT-CO1/COX1 and MT-ND6/ND6 open reading frames, respectively . Recognizes non-canonical stop codons via a network of interactions between the codon, MTRF1 and the ribosomal RNA (rRNA): in contrast to other translation release factors, which identify the codon in the A-site via direct interactions of amino acid side chains with the bases, MTRF1 repositions the first 2 bases of the stop codon to use an intricate network of interactions that includes residues of the release factor, the rRNA of the small ribosomal subunit, as well as neighboring bases of the mRNA . . |
Accessions | ENST00000379477.5 [O75570-1] Q8N6Z2 A0A087WZ41 A0A087X1S1 ENST00000497679.6 ENST00000430347.3 X6RFD4 ENST00000452359.5 ENST00000379480.9 [O75570-1] ENST00000480434.5 O75570 ENST00000239852.10 |